Reuters logo
BRIEF-OSE Immunotherapeutics publishes new data on FR104, CD28-Antagonist Immunotherapy​
October 19, 2017 / 5:08 PM / a month ago

BRIEF-OSE Immunotherapeutics publishes new data on FR104, CD28-Antagonist Immunotherapy​

Oct 19 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:

* ‍OSE IMMUNOTHERAPEUTICS PUBLISHES NEW DATA ON FR104, CD28-ANTAGONIST IMMUNOTHERAPY​

* ‍ANNOUNCES POSITIVE RESULTS OF TWO PRECLINICAL STUDIES EVALUATING FR104​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below